CytomX Therapeutics Inc.

NASDAQ: CTMX · Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT

CytomX Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
38.05M 17.17M 193.65M 205.53M
Short-Term Investments
62.57M 157.34M n/a 99.7M
Long-Term Investments
n/a n/a 917K 917K
Other Long-Term Assets
1.09M 1M -3.57M -3.71M
Receivables
3.1M 3.43M 35.99M 790K
Inventory
n/a n/a n/a n/a
Other Current Assets
3.58M 5M 7.47M 4.29M
Total Current Assets
107.31M 182.94M 237.1M 310.3M
Property-Plant & Equipment
10.6M 16.18M 21.02M 25.32M
Goodwill & Intangibles
1.53M 1.68M 1.82M 1.97M
Total Long-Term Assets
13.23M 18.86M 23.79M 29.11M
Total Assets
120.53M 201.79M 260.89M 339.41M
Account Payables
1.09M 1.46M 2.81M 2.82M
Deferred Revenue
67.2M 132.27M 121.27M 69.26M
Short-Term Debt
5.14M n/a n/a n/a
Other Current Liabilities
12.34M 9.44M 16.39M 21.04M
Total Current Liabilities
85.77M 155.91M 152.61M 106.32M
Long-Term Debt
n/a n/a 13.97M 18.06M
Other Long-Term Liabilities
4.12M 3.89M -13.97M 100.23M
Total Long-Term Liabilities
35.22M 93.33M 194.03M 143.72M
Total Liabilities
120.99M 249.24M 346.64M 250.03M
Total Debt
9.38M 13.97M 18.06M 18.06M
Common Stock
1K 1K 1K 1K
Retained Earnings
-691.58M -723.45M -722.88M -533.72M
Comprehensive Income
27K 95K 10K -242K
Shareholders Equity
-456K -47.45M -85.75M 89.38M
Total Investments
62.57M 157.34M 917K 99.7M